लोड हो रहा है...

Lessons From Immune Checkpoint Inhibitor Trials in Hepatocellular Carcinoma

The implementation of immune checkpoint inhibitors (ICI) into the clinical management of different malignancies has largely changed our understanding of cancer treatment. After having proven efficacy in different tumor entities such as malignant melanoma and lung cancer, ICI were intensively tested...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Front Immunol
मुख्य लेखकों: Mohr, Raphael, Jost-Brinkmann, Fabian, Özdirik, Burcin, Lambrecht, Joeri, Hammerich, Linda, Loosen, Sven H., Luedde, Tom, Demir, Münevver, Tacke, Frank, Roderburg, Christoph
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Frontiers Media S.A. 2021
विषय:
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC8042255/
https://ncbi.nlm.nih.gov/pubmed/33859646
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.652172
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!